Featured post

SCS research and awards news

For all our research and awards news, please visit our news page.

Showing posts with label Michael Fahey. Show all posts
Showing posts with label Michael Fahey. Show all posts

Thursday, 5 March 2020

Fulbright Fellow Michael Fahey travels to US to promote better outcomes for Cerebral Palsy

Dr Kruer and Assoc. Prof Michael Fahey
SCS Associate Professor Michael Fahey has spent the past three months at the University of Arizona College of Medicine – Phoenix as a Fulbright Fellow where he has cultivated relationships with institutions across the U.S. to help advance the work and understanding of cerebral palsy and genetics.

Tuesday, 4 December 2018

Monash University’s Fulbright scholar aiming for personalised treatment for cerebral palsy

Associate Professor Michael Fahey

Associate Professor Michael Fahey from Monash University’s School of Clinical Sciences at Monash Health (SCS), has been awarded a prestigious Fulbright scholarship to better understand the neurology and genetics in people affected by cerebral palsy.

Monday, 25 June 2018

Cerebral Palsy research receives funding boost from MRFF


Last Saturday, Professor Euan Wallace, Associate Professor Michael Fahey, Dr Tim Moss and Dr Stacey Ellery attended the Grace Gala ball in Sydney to accept a cheque for $2 million from Australia's Medical Research Future Fund (MRFF), to the Cerebral Palsy (CP) Alliance research foundation.


Monday, 5 March 2018

High-level mobility training benefits people with neurological impairment

Ms Tanja Spencer
A world-first study at the Monash Health Translation Precinct (MHTP) evaluating high-level mobility training in people with a neurological impairment has revealed the benefits of interventions.

Led by Monash Children’s Hospital physiotherapist Ms Tanja Spencer and Associate Professor Michael Fahey from Monash University’s Department of Paediatrics, the study was published last month in Brain Injury.

Neurological impairments such as acquired brain injury, spinal cord injury and cerebral palsy are a leading cause of disability worldwide.

Although many people with a neurological impairment can walk unaided, they still identify difficulty with high-level mobility skills.

“High-level mobility skills include activities beyond independent walking, such as running and jumping,” Ms Spencer said.

“Importantly, these skills facilitate participation in community life, sports and employment, and are therefore worthy of targeted intervention.”

Ms Spencer said the study is the very first systematic review to evaluate the emerging literature regarding high-level mobility interventions in people with a neurological impairment.

“Our findings provide evidence to support the role of various interventions in safely improving high-level mobility skills for a wide range of neurological diagnoses and participant ages,” Ms Spencer said.

Associate Professor Fahey said people with neurological impairment are often discharged from rehabilitation once they have achieved safe, independent ambulation and face challenges such as lack of funding for, and access to appropriate programs that address high-level mobility. 

“This study shows that clinicians can reasonably implement high-level mobility interventions in ambulant people with a neurological impairment, who have goals to do more than walk over level surfaces,” Associate Professor Fahey said. 

The research team is hopeful the systematic review will encourage physiotherapists to support their clients with a neurological impairment in pursuing their goals of returning to or improving their running, and sports participation. 

Ms Spencer has recently completed her Masters of Philosophy through Monash University’s Department of Paediatrics.

This research was initiated after a Running Group offered through the Victorian Paediatric Rehabilitation Service at Monash Children’s Hospital yielded positive results for children with neurological impairments.  An Emerging Researcher Fellowship from Monash Health allowed Tanja to finalise this systematic review and undertake a randomised controlled trial comparing the Running Group to usual care.  The results of that study have been widely presented at national and international childhood disability conferences and are currently being reviewed for publication.